Xenon Pharmaceuticals
XENE · NASDAQ
Bulios Fair Price
$35.06
40.4% downside
Trenutna cena
$58.8
Po podatkih Bulios Fair Price je delnica XENE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Xenon Pharmaceuticals is a biotechnology company focused on developing innovative therapies for the treatment of neurological and genetic disorders. The company specializes in discovering and developing new drugs that target specific genetic pathways and ion channels critical for the proper functioning of the nervous system. Xenon focuses on rare and difficult-to-treat disorders, such as epilepsy and various neurological conditions caused by genetic mutations. The company utilizes advanced technologies to accelerate the development of these therapeutics and improve the lives of patients suffering from these diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Ian C. Mortimer
Employees
364
Headquarters
Burnaby
Prihajajoči dogodki
Earnings
Upcoming earnings report